Biotech, Clinical Research, Pharmaceutical News & Jobs

BioSpace Login

Enter your BioSpace account email address and password to log in now.

Email Address

Password

Keep me logged in

Close Window

Forgot Your Password? | Privacy Statement

NEW MEMBER SIGN UP

Display Name

Email Address

Password

Password again

Zip

Country

Close Window

Privacy Statement

Biotech and Pharmaceutical
News & Jobs

Search the Site

Community Login

What is this?

Employers
Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
BioPharm Insight

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

Saturday, September 04, 2010

Celldex Therapeutics, Inc. (CLDX) Says Pfizer Inc. (PFE) Ends Cancer Vaccine Deal; Celldex Shares Fall 26.15% at 12:59PM EDT More...

Roche (RHHBY) to Cut Costs, Review Business After Drug Setbacks; No Details on Size of Cost Reductions or the Number of Staff, Units Affected, Detailed Steps Will be Announced Late 2010 More...

Santhera Pharmaceuticals AG (SANN.SW) and Ipsen Enter into Licensing Agreement for Fipamezole for the Treatment of Dyskinesia in Parkinson's Disease; Upfront Payment of 13 Million Euros With Another Milestones of Up To 128 Million Euros More...

Ads for Sepracor's Lunesta, Novartis Corporation (NVS)'s Tasigna Among Those Warned by FDA More...

Abbott Laboratories (ABT) Calls Off Sale Of Flu Vaccine Business In Europe More...

University of Alabama at Birmingham Logs Another Spinoff With Soluble Therapeutics; Company Technology Could Speed Drug Delivery Time to Six Weeks More...

AstraZeneca PLC (AZN)'s Seroquel XR Gets EC Approval More...

BioDelivery Sciences International (BDSI) Calls Meeting With FDA Positive; BioDelivery Sciences Hopes to Increase Access to Cancer-Pain Drug More...

Market Summary

Symbol Lookup

Takeda Pharmaceutical Co. Ltd. (TKDG.DE) And Orexigen Therapeutics, Inc. (OREX) Sign $1 Billion Obesity Pact More...

FDA Staff Say Forest Laboratories, Inc. (FRX) Antibiotic Seems Effective More...

SinoBiomed Inc. (SOBM) Announces New Chief Executive Officer More...

Roche (RHHBY) Plans Massive Job Cuts, No Decision This Week More...

'Brain Exercise' May Worsen Existing Alzheimer's, Rush University Medical Center Study More...

Cancer Drug Gleevec May Offer Clue to Alzheimer's Cure, Study Published in Nature More...

FDA Warns On Increased Death Risk With Pfizer Inc. (PFE) Antibiotic Tygacil More...

New Evidence that Fat Cells are Not Just Dormant Storage Depots for Calories, Study Published in Journal of Proteome Research More...

Merck & Co., Inc. (MRK) Postpones Dutch Closures, Options Open More...

Pfizer Inc. (PFE) to Acquire FoldRx Pharmaceuticals, Inc. for Undisclosed Amount, Looks to Expand Developmental Pipeline More...





		Advanced Search

Hair Provides Proof of the Link Between Chronic Stress and Heart Attack, University of Western Ontario Study More...

Common Bone Drugs Linked to Esophageal Cancer Risk, University of Oxford Study More...

Double-Dose Plavix Benefits Certain Patients, Columbia University Study Finds More...

Diabetes Drug Metformin Linked to Lower Lung Cancer Rate in Mice, University of Texas MD Anderson Cancer Center Study More...

Age No Barrier to Oral Anticoagulants, University of Birmingham Study More...

Study Links Intermediary Cells to Triple-Negative Breast Cancer, Breakthrough Breast Cancer's Institute of Cancer Research Study More...

Protecting the Lungs Against 'Collateral Damage' from the Immune System, University of Alabama at Birmingham Study More...

Scientists Unwrap DNA Packaging to Gain Insight Into Cells, University of Edinburgh and Collaborators Study More...

Miltenyi Biotec, Inc.	Marketing Product Manager
Vertex Pharmaceuticals, Inc	Analytical Chemist/ Sr. Scientific Associate
Lawrence Berkeley National Laboratory	Software Developer 3 - Sequence Data Management
Vertex	Director, Alliance Management
Tanabe Research Laboratories	Research Associate / Senior Research Associate Positions

Vertex Pharmaceuticals is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company’s strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex’s product pipeline is focused on viral diseases, inflammation, autoimmune diseases, cancer, pain and bacterial infection. Vertex co-discovered the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.
NEW! View Vertex's latest job posting: Director, Alliance Management

Show me jobs for this employer

Top 20 Common Interview Questions and Answers More...

Managing Older Managers: A Guide for Younger Bosses More...

Best Questions To Ask In Your Job Interview More...

Six Ways To Write Cover Letters They Won't Throw Out More...

How To Beat The Negative Thoughts Ruining Your Job Search More...

5 Strategies For Surviving The 'New Normal' Job Market More...

The Young and Successful Job Search More...

The Art Of Writing A Cover Letter More...

Job Hunting Online: What To Do And What Not To Do More...

Affirmative Action: How Far Have We Come? More...